India Pharma Outlook Team | Monday, 26 October 2026
Breast cancer screening remains a public health challenge in Uttar Pradesh, where delays in diagnostic follow-up are limiting the benefits of early detection.
A report from King George’s Medical University (KGMU), Lucknow, highlights a significant gap between identifying breast abnormalities and completing further medical checkups.
Of 51,894 women screened in a study cited by KGMU experts, approximately 1,557 had abnormal breast examination findings, but only around 639, or 41 percent, visited a diagnostic facility for further evaluation.
This means nearly 59 percent did not complete this step.
The findings raise questions about referral systems, financial barriers, and patient support, as well as how healthcare providers can improve continuity between initial screening and diagnosis.
While clinical breast examinations can identify potential abnormalities, they cannot independently confirm whether a woman has cancer. Further evaluation is necessary to establish a diagnosis and determine whether treatment is required.
According to the KGMU report, women face multiple barriers to completing these investigations. These include fear of a possible cancer diagnosis, social stigma surrounding breast examinations, financial hardship, transport difficulties, and lost wages.
These challenges demonstrate why breast cancer screening cannot be assessed solely by the number of women examined. If patients do not complete follow-up investigations, opportunities to identify and manage the disease at an earlier stage may be missed.
Women may require additional visits, specialist referrals and assistance navigating healthcare facilities, creating practical obstacles even after an abnormality has been identified.
Also Read: India's Role in Shaping the Future of Oncology and Immunology
KGMU experts have recommended greater involvement of Accredited Social Health Activists (ASHA workers) and mobile phone-based support to help women navigate diagnostic services.
Community health workers could help patients understand referral instructions, remind them about appointments, and identify practical barriers that prevent them from reaching diagnostic facilities.
Such interventions would need to connect women with functioning diagnostic facilities and appropriate specialist care. Reminders alone cannot resolve problems involving transport costs, lost income, or inadequate access to services.
Local health systems would therefore need to combine patient tracking with counseling and practical assistance.
The findings point to the need for a broader approach to breast cancer screening in India, with greater attention to what happens after an abnormal result. Healthcare system needs to assess whether patients complete diagnostic investigations and receive appropriate care.
Potential indicators include the proportion of women referred for further testing who attend diagnostic facilities, the time between an abnormal examination and confirmation, and the number of patients who proceed to treatment when required.
The KGMU report also highlights the consequences of delayed presentation. Experts said nearly seven in 10 women diagnosed with breast cancer reach hospitals with advanced disease, limiting treatment options.
Ultimately, improving early detection requires more than encouraging women to undergo examinations. Stronger referral mechanisms, accessible diagnostic services, and consistent patient follow-up are necessary to turn screening into timely diagnosis and appropriate care.
.jpg)
